Corvus Pharmaceuticals (CRVS) Non-Current Deffered Revenue (2015 - 2018)

Corvus Pharmaceuticals' Non-Current Deffered Revenue history runs 4 years deep, the most recent figure standing at $869000.0 for Q4 2018.

• In Q4 2018, Non-Current Deffered Revenue fell 9.48% year-over-year to $869000.0; the TTM figure through Dec 2018 stood at $869000.0 (down 9.48% YoY), while the FY2018 annual figure was $869000.0, down 9.48% from the prior year.
• Non-Current Deffered Revenue was $869000.0 for Q4 2018 at Corvus Pharmaceuticals, up from $627000.0 in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $1.4 million in Q4 2016 to a low of $627000.0 in Q3 2018.
• Historically, Non-Current Deffered Revenue has averaged $1.0 million across 4 years, with a median of $1.1 million in 2017.
• The sharpest annual moves came in 2016 and 2018: Non-Current Deffered Revenue surged 113.4% in 2016, then slumped 41.02% in 2018.
• A 4-year view of Non-Current Deffered Revenue shows it stood at $642000.0 in 2015, then surged by 113.4% to $1.4 million in 2016, then declined by 29.93% to $960000.0 in 2017, then declined by 9.48% to $869000.0 in 2018.
• The last three Non-Current Deffered Revenue figures came in at $869000.0 (Q4 2018), $627000.0 (Q3 2018), and $738000.0 (Q2 2018), per Business Quant data.